Author: Sallard, Erwan; Lescure, François-Xavier; Yazdanpanah, Yazdan; Mentre, France; Peiffer-Smadja, Nathan
Title: Type 1 interferons as a potential treatment against COVID-19 Cord-id: a0ribcmv Document date: 2020_4_7
ID: a0ribcmv
Snippet: Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19.
Document: Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the potential activity of type 1 interferons on SARS-CoV-2, and the relevance of evaluating these molecules in clinical trials for the treatment of COVID-19.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and administration mode: 1
- acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- acute ards respiratory distress syndrome and lopinavir ritonavir combination: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lung pathology: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- acute ards respiratory distress syndrome and lung pathology severity: 1
- adaptive immunity and lopinavir ritonavir: 1, 2
- adaptive immunity and lung pathology: 1, 2, 3
- administration mode and lung pathology: 1
Co phrase search for related documents, hyperlinks ordered by date